Ask Warren

Hanmi Pharm

128940 · KOSPI · ₩128940 · 한미약품

₩369,500▲ ₩19,000 (5.42%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩467B₩393B₩433B₩362B₩361B₩391B₩352B₩362B
Cost of sales₩164B₩176B₩172B₩157B₩157B₩177B₩166B₩163B
Gross profit₩303B₩217B₩260B₩206B₩205B₩214B₩185B₩199B
Operating income₩131B₩54B₩83B₩55B₩60B₩59B₩30B₩51B
Net income₩33B₩51B₩142B₩2.4B−₩1.6B₩45B₩105B−₩12B
Net income to shareholders₩83B₩45B₩48B₩40B₩39B₩43B−₩5B₩31B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩2.3T₩2.2T₩2.1T₩2T₩2T₩2T₩2T₩2T
Current assets₩1.2T₩983B₩894B₩820B₩737B₩720B₩746B₩721B
Cash and equivalents₩209B₩140B₩108B₩84B₩79B₩84B₩192B₩48B
Total liabilities₩745B₩747B₩715B₩695B₩683B₩715B₩780B₩726B
Current liabilities₩635B₩638B₩605B₩586B₩596B₩623B₩683B₩623B
Borrowings₩91B₩409B₩425B₩426B₩429B₩464B₩488B₩494B
Total equity₩1.6T₩1.5T₩1.4T₩1.3T₩1.3T₩1.3T₩1.2T₩1.2T
Shareholders' equity₩1.4T₩1.3T₩1.2T₩1.2T₩1.1T₩1.1T₩1.1T₩1.1T

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩105B₩112B₩15B₩42B₩37B₩79B₩15B₩20B
Capital spending₩21B₩15B₩9.8B₩11B₩16B₩6.2B₩12B₩7.3B
Free cash flow₩83B₩97B₩4.7B₩31B₩21B₩73B₩2.6B₩13B
Dividends paid₩35B₩0₩105M−₩3B₩17B₩16B₩106M₩3.2B

Consolidated where available. Amounts in won.

Also known as: Hanmi Pharm / 한미약품 / 128940 / KRX:128940

Source: KRX statistical information